Taming the Ketamine Tiger

被引:384
作者
Domino, Edward F. [1 ]
机构
[1] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
MAJOR DEPRESSIVE DISORDER; NMDA ANTAGONIST; SUBANESTHETIC KETAMINE; NITROUS-OXIDE; PHENCYCLIDINE; MODEL; DRUG; GAS; METABOLITES; ANESTHETICS;
D O I
10.1097/ALN.0b013e3181ed09a2
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Pharmacologic actions of CI-581, a chemical derivative of phencyclidine, were determined in 20 volunteers from a prison population. The results indicate that this drug is an effective analgesic and anesthetic agent in doses of 1.0 to 2.0 mg per kilogram. With intravenous administration the onset of action is within 1 min and the effects last for about 5 to 10 min, depending on dosage level and individual variation. No tachyphylaxis was evident on repeat doses. Respiratory depression was slight and transient. Hypertension, tachycardia, and psychic changes are undesirable characteristics of the drug. Whether these can be modified by preanesthetic medication was not determined in this study. Recovery from analgesia and coma usually took place within 10 min, although from electroencephalographic evidence it may be assumed that subjects were not completely normal until after 1 to 2 h. No evidence of liver or kidney toxicity was obtained. CI-581 produces pharmacologic effects similar to those reported for phencyclidine, but of shorter duration. The drug deserves further pharmacologic and clinical trials. It is proposed that the words "dissociative anesthetic" be used to describe the mental state produced by this drug.
引用
收藏
页码:678 / 684
页数:7
相关论文
共 61 条
[1]   THE DISSOCIATIVE ANESTHETICS, KETAMINE AND PHENCYCLIDINE, SELECTIVELY REDUCE EXCITATION OF CENTRAL MAMMALIAN NEURONS BY N-METHYL-ASPARTATE [J].
ANIS, NA ;
BERRY, SC ;
BURTON, NR ;
LODGE, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 79 (02) :565-575
[2]   Dextromethorphan and ketamine potentiate the antinociceptive effects of μ- but not δ- or κ-opioid agonists in a mouse model of acute pain [J].
Baker, AK ;
Hoffmann, VLH ;
Meert, TF .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 74 (01) :73-86
[3]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[4]  
CHARNEY DS, 2007, Patent No. 20070287753
[5]  
CHEN G, 1959, J PHARMACOL EXP THER, V127, P241
[6]   SENSORY ISOLATION - HALLUCINOGENIC EFFECTS OF A BRIEF PROCEDURE [J].
COHEN, BD ;
ROSENBAUM, G ;
DOBIE, SI ;
GOTTLIEB, JS .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1959, 129 (05) :486-491
[7]   Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions [J].
Correll, GE ;
Futter, GE .
PAIN MEDICINE, 2006, 7 (01) :92-95
[8]  
CORSSEN G, 1966, ANESTH ANAL CURR RES, V45, P29
[9]   EVIDENCE FOR INVOLVEMENT OF N-METHYLASPARTATE RECEPTORS IN WIND-UP OF CLASS-2 NEURONS IN THE DORSAL HORN OF THE RAT [J].
DAVIES, SN ;
LODGE, D .
BRAIN RESEARCH, 1987, 424 (02) :402-406
[10]  
DOMINO E F, 1981, University of Michigan Medical Center Journal, V47, P1